<img alt="" height="1" width="1" />
Teva&#39;s Copaxone Successor Fails in Latest Clinical Trial
Aug. 1 (Bloomberg) -- Teva Pharmaceutical Industries Ltd.&#39;s experimental multiple sclerosis pill failed to reduce relapses more than placebo in a clinical trial, dealing a blow to the company&#39;s effort to find a successor to an older ...
Teva&#39;s Oral Multiple-Sclerosis Drug Fails to Meet Goal of Clinical TrialBloomberg
Teva, Active Biotech Multiple Sclerosis Treatment Misses Primary GoalWall Street Journal
Teva&#39;s oral MS drug trips (again) in blockbuster Ph3 development raceFierceBiotech
Middle East North Africa Financial Network -Reuters (press release) -Globes
all 40 news articles &raquo;